Titan Pharmaceuticals's total assets for Q were $4.35M, a decrease of -34.55% from the previous quarter. TTNP total liabilities were $356.00K for the fiscal quarter, a -36.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.